Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hAESCs Transplantation for Parkinson's Disease
NCT04414813Phase 1Completed
- Sponsor
- Shanghai East Hospital
- Start
- Oct 2020
- Primary completion
- Feb 2023
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
Phase 1, open-label trial of human amniotic epithelial stem cells in Parkinson's disease (PD), sponsored by Shanghai East Hospital. Primary endpoint: Number of Participants with adverse event and serious adverse event at 12 months. Started Oct 2020; status: completed.
02
Drugs
human amniotic epithelial stem cells
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04414813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04414813.